| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028498 |
| Receipt No. | R000032614 |
| Official scientific title of the study | Examination on an influence of continued use of plant-based carbon fiber on muscle stiffness |
| Date of disclosure of the study information | 2017/08/10 |
| Last modified on | 2018/03/01 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Examination on an influence of continued use of plant-based carbon fiber on muscle stiffness | |
| Title of the study (Brief title) | Examination on an influence of continued use of plant-based carbon fiber on muscle stiffness | |
| Region |
|
|
| Condition | |||
| Condition | Shoulder stiffness, lower back pain, and poor blood circulatio
|
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine effects of bedding that contains plant-based carbon fiber on nutritional requirement, muscle hardness, and blood circulation. To conduct a study on a commercially available product to examine effects thereof on actual use.
|
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Nutritional requirement through analysis of expired gas
Muscle hardness Blood flow rate Survey on subjective symptoms |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | 2-week use of the test product | |
| Interventions/Control_2 | 2-week use of the placebo product | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.Age: 30 and over, below 80
2.Sex: Female 3.Subjective symptoms of shoulder stiffness, lower back pain, and poor blood circulation. 4.Persons who voluntarily agree to participate in this study. 5.Persons with a habit of sleeping on a futon or bed alone. |
|||
| Key exclusion criteria | 1.Currently seeing a doctor in treatment of or previous history of shoulder stiffness, lower back pain, and/or poor blood circulation
2.Regular intake of medication or supplements for shoulder stiffness, lower back pain, and/or poor blood circulation 3.Currently in treatment with medication 4.Presence or previous history of a severe disorder(s) such as diabetes, a circulatory disease, a hepatic disease, a renal disease, or a cardiac disease 5.Currently seeing a doctor in treatment of or previous history of Intervertebral disk displacement or rheumatism 6.BMI of below 18.5, 25.0 and higher 7.Working on night shift or with alternative work schedule 8.Current participation in another clinical trial (including studies on food products and cosmetics) 9.Presence or previous history of psychiatric visits for depression, a sleep disorder, etc. 10.Nursing or pregnant, or desired to become pregnant during the study 11.Determined by the investigator to be unsuitable for enrollment in this study |
|||
| Target sample size | 12 | |||
| Research contact person | |
| Name of lead principal investigator | Ochitani Daisuke |
| Organization | HUMA R&D CORP |
| Division name | Clinical Development Division |
| Address | Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan |
| TEL | 81-3-3431-1260 |
| ochitani@huma-c.co.jp | |
| Public contact | |
| Name of contact person | Ochitani Daisuke |
| Organization | HUMA R&D CORP |
| Division name | Clinical Development Division |
| Address | Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan |
| TEL | 81-3-3431-1260 |
| Homepage URL | |
| ochitani@huma-c.co.jp | |
| Sponsor | |
| Institute | HUMA R&D CORP |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ORGAHEXA Inc |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032614 |